HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ventricular pacing in the presence of tricuspid valve disease.

Abstract
Pacemaker implantation following tricuspid valve surgery remains challenging, but recent developments in lead technology have significantly improved the options for ventricular pacing. In the presence of significant tricuspid regurgitation, steroid-eluting active-fixation leads should be used routinely, and in patients with a tricuspid prosthesis, the use of a dedicated cardiac venous pacing system is likely to be the best option.
AuthorsNeil C Davidson, Harry G Mond
JournalPacing and clinical electrophysiology : PACE (Pacing Clin Electrophysiol) Vol. 25 Issue 2 Pg. 129-31 (Feb 2002) ISSN: 0147-8389 [Print] United States
PMID11915977 (Publication Type: Comment, Editorial)
Topics
  • Ebstein Anomaly (therapy)
  • Electrodes, Implanted
  • Heart Valve Prosthesis Implantation
  • Humans
  • Pacemaker, Artificial
  • Tricuspid Valve (surgery)
  • Tricuspid Valve Insufficiency (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: